| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 55.5465 | 60 |
| GSM780708 | Untreated after 4 days (C2_1) | 53.5306 | 57 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.5304 | 55 |
| GSM780719 | Untreated after 4 days (C1_2) | 60.4928 | 65 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.559 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.2299 | 54 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.4758 | 53 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 54.67 | 59 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.8646 | 62 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 59.4534 | 64 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.6523 | 55 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 55.3825 | 60 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 55.0851 | 60 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.606 | 47 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.167 | 46 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 59.5322 | 64 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.8361 | 59 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.641 | 55 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 56.2451 | 61 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 55.4643 | 60 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.9601 | 56 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 53.019 | 56 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.4434 | 57 |